Related references
Note: Only part of the references are listed.Clinical Pharmacokinetics of Triazoles in Pediatric Patients
Didi Bury et al.
CLINICAL PHARMACOKINETICS (2021)
Effective plasma concentrations of itraconazole and its active metabolite for the treatment of pulmonary aspergillosis
Yaeko Nakamura et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2020)
Sex differences in pharmacokinetics predict adverse drug reactions in women
Irving Zucker et al.
BIOLOGY OF SEX DIFFERENCES (2020)
Bioequivalence for highly variable drugs: regulatory agreements, disagreements, and harmonization
Laszlo Endrenyi et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2019)
Therapeutic drug monitoring of systemic antifungal agents: a pragmatic approach for adult and pediatric patients
Jamie John et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2019)
Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a century
Sarah Watson et al.
ECLINICALMEDICINE (2019)
Population in vitro-in vivo pharmacokinetic model of first-pass metabolism: itraconazole and hydroxy-itraconazole
Ahmad Y. Abuhelwa et al.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2018)
Bioequivalence study of two formulations of itraconazole 100 mg capsules in healthy volunteers under fed conditions: a randomized, three-period, reference-replicated, crossover study
Viktorija Dragojevic-Simic et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2018)
Physiologically Based Pharmacokinetic Model of Itraconazole and Two of Its Metabolites to Improve the Predictions and the Mechanistic Understanding of CYP3A4 Drug-Drug Interactions
Luna Prieto Garcia et al.
DRUG METABOLISM AND DISPOSITION (2018)
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
Frederic Tissot et al.
HAEMATOLOGICA (2017)
ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients
Frederic Tissot et al.
HAEMATOLOGICA (2017)
Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients
Romuald Bellmann et al.
INFECTION (2017)
Serum levels, safety and tolerability of new formulation SUBA-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantation
Julian Lindsay et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children
Sarah Allegra et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2017)
Gender-based personalized pharmacotherapy: a systematic review
Md. Mohaimenul Islam et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2017)
Population In Vitro-In Vivo Correlation Model Linking Gastrointestinal Transit Time, pH, and Pharmacokinetics: Itraconazole as a Model Drug
Ahmad Y. Abuhelwa et al.
PHARMACEUTICAL RESEARCH (2016)
Itraconazole: an update on pharmacology and clinical use for treatment of invasive and allergic fungal infections
Jodi Lestner et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2013)
Age-Related Changes in Pharmacokinetics
Shaojun Shi et al.
CURRENT DRUG METABOLISM (2011)
Sex Differences in Drug Disposition
Offie P. Soldin et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Increased Oral Bioavailability of Itraconazole and Its Active Metabolite, 7-Hydroxyitraconazole, When Coadministered With a Vitamin C Beverage in Healthy Participants
Soo Kyung Bae et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
CYP1A1 GENOTYPE MODIFIES THE IMPACT OF SMOKING ON EFFECTIVENESS OF HAART AMONG WOMEN
David N. Feldman et al.
AIDS EDUCATION AND PREVENTION (2009)
Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2008)
Single-dose pharmacokinetics of intravenous itraconazole and hydroxypropyl-β-cyclodextrin in infants, children, and adolescents
Susan M. Abdel-Rahman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Comparative analysis of the effects of rice and bread meals on bioavailability of itraconazole using NONMEM in healthy volunteers
Hwi-yeol Yun et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients
Stefanie Hennig et al.
CLINICAL PHARMACOKINETICS (2006)
Sex and racial differences in pharmacological response: Where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics
GD Anderson
JOURNAL OF WOMENS HEALTH (2005)
History of the development of azole derivatives
JA Maertens
CLINICAL MICROBIOLOGY AND INFECTION (2004)
Role of itraconazole metabolites in CYP3A4 inhibition
N Isoherranen et al.
DRUG METABOLISM AND DISPOSITION (2004)
Population pharmacokinetics of itraconazole in Thai HIV-1-Infected persons
CHW Koks et al.
THERAPEUTIC DRUG MONITORING (2003)
Gender differences in drug effects: implications for anesthesiologists
H Pleym et al.
ACTA ANAESTHESIOLOGICA SCANDINAVICA (2003)
Now important are gender differences in pharmacokinetics?
B Meibohm et al.
CLINICAL PHARMACOKINETICS (2002)
Share Paper
